Standout Papers

Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy d... 2021 2026 2022 2024232
  1. Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies (2021)
    Anat Achiron, Mathilda Mandel et al. Therapeutic Advances in Neurological Disorders

Immediate Impact

1 by Nobel laureates 9 from Science/Nature 67 standout
Sub-graph 1 of 21

Citing Papers

Polymeric Nanoparticles for Drug Delivery
2024 Standout
Small and long non-coding RNAs: Past, present, and future
2024 Standout
2 intermediate papers

Works of Gil Harari being referenced

RNAi therapy targeting KRAS in combination with chemotherapy for locally advanced pancreatic cancer patients
2015

Author Peers

Author Last Decade Papers Cites
Gil Harari 427 287 274 385 63 1.9k
Iona Y. Millwood 289 171 482 592 98 2.9k
Cristina Pellegrino Baena 453 60 276 214 85 2.1k
Markus Velten 124 276 136 381 88 1.9k
Yu‐Ming Niu 196 63 224 504 72 2.7k
William F. Page 583 123 148 222 67 2.8k
Pekka Laippala 208 164 275 203 75 2.4k
Hung‐Pin Tu 245 130 203 470 143 2.3k
Ghazi Zaatari 225 210 620 401 126 2.6k
Cindy M. Chang 218 194 575 425 55 1.9k
Peng Zhang 138 129 117 242 88 1.5k

All Works

Loading papers...

Rankless by CCL
2026